KHTRF (Knight Therapeutics) Short Percentage of Float


KHTRF Knight Therapeutics Inc KHTRF
71 GF Score
Price $6.99
GF Value $6.16
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Knight Therapeutics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

KHTRF vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Knight Therapeutics Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's Short Percentage of Float falls into.


KHTRF
71GF Score
Knight Therapeutics Inc KHTRF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Knight Therapeutics (KHTRF) Overvalued in 2026?

Based on GuruFocus' analysis, Knight Therapeutics stock appears to be overvalued. The current stock price of $6.99 is trading 13.5% above its estimated GF Value™ of $6.16. GuruFocus considers Knight Therapeutics to be Modestly Overvalued.

Key valuation signals for KHTRF:

  • Short Percentage of Float:
  • GF Value™: $6.16 vs. price of $6.99 (13.5% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the KHTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Knight Therapeutics Business Description

Other Exchanges GUD:Canada
Address 100 Alexis Nihon Boulevard, Suite 600, Saint-Laurent, QC, CAN, H4M 2P2
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.
71GF Score

Get the complete analysis for KHTRF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.99
Price
$6.16
GF Value